ImmunityBio, Inc. (IBRX)
ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The company also develops therapeutic agents, which are in Phase II or III clinical trial for the treatment of liquid and solid tumors, including bladder, pancreatic, and lung cancers, as well as pathogens as SARS-CoV-2 and HIV. It has collaboration agreements with National Cancer Institute, National Institute of Deafness and Communication Disorders, and Amyris, Inc.; and license agreements with CytRx Corporation, EnGeneIC Pty Limited, GlobeImmune, Inc., and Infectious Disease Research Institute, Sanford Health, Shenzhen Beike Biotechnology Co. Ltd., Sorrento Therapeutics, Inc., and Viracta Therapeutics, Inc. The company was founded in 2014 and is based in San Diego, California.
$3.45B
Mr. Richard Gerald Adcock
760.00
San Diego, CA
Mar 10, 2021
-5.16
$-0.96
2.09
3.91
-45,691.67%
-6.26
0.45
-5.36
2,902.22
3.88
-134.51%
100.06%
Similar stocks (9)
Madrigal Pharmaceuticals, Inc.
MDGL
Krystal Biotech, Inc.
KRYS
Ardelyx, Inc.
ARDX
Lexicon Pharmaceuticals, Inc.
LXRX
Seres Therapeutics, Inc.
MCRB
PDS Biotechnology Corporation
PDSB
Protalix BioTherapeutics, Inc.
PLX
Elevation Oncology, Inc.
ELEV
eFFECTOR Therapeutics, Inc.
EFTR
ETF Exposure (19)
Loncar Cancer Immunotherapy ETF
CNCR
3.28%
ETFMG Treatments, Testing and Advancements ETF
GERM
3.14%
iShares Genomics Immunology and Healthcare ETF
IDNA
0.89689%
Invesco Nasdaq Biotechnology ETF
IBBQ
0.369%
Direxion Daily S&P Biotech Bull 3X Shares
LABU
0.2184996758%
First Trust Small Cap Growth AlphaDEX Fund
FYC
0.16%
ProShares Ultra Nasdaq Biotechnology
BIB
0.1034666679171907%
iShares Russell 2000 Growth ETF
IWO
0.04187%
First Trust Multi Cap Growth AlphaDEX Fund
FAD
0.03%
iShares Russell 2000 ETF
IWM
0.02712%
Schwab U.S. Small-Cap ETF
SCHA
0.0153420885%
iShares Russell 2000 Value ETF
IWN
0.01309%
Vanguard Small Cap Index Fund
NAESX
0.01%
Fidelity MSCI Health Care Index ETF
FHLC
0.00776056%
ProShares Hedge Replication ETF
HDG
0.004018517971837164%
iShares Core S&P Total U.S. Stock Market ETF
ITOT
0.00171%
iShares Russell 3000 ETF
IWV
0.00167%
Schwab U.S. Broad Market ETF
SCHB
9.08584e-4%
Goldman Sachs ActiveBeta U.S. Small Cap Equity ETF
GSSC
0%
Similar stocks (9)
Madrigal Pharmaceuticals, Inc.
MDGL
Krystal Biotech, Inc.
KRYS
Ardelyx, Inc.
ARDX
Lexicon Pharmaceuticals, Inc.
LXRX
Seres Therapeutics, Inc.
MCRB
PDS Biotechnology Corporation
PDSB
Protalix BioTherapeutics, Inc.
PLX
Elevation Oncology, Inc.
ELEV
eFFECTOR Therapeutics, Inc.
EFTR
ETF Exposure (19)
Loncar Cancer Immunotherapy ETF
CNCR
3.28%
ETFMG Treatments, Testing and Advancements ETF
GERM
3.14%
iShares Genomics Immunology and Healthcare ETF
IDNA
0.89689%
Invesco Nasdaq Biotechnology ETF
IBBQ
0.369%
Direxion Daily S&P Biotech Bull 3X Shares
LABU
0.2184996758%
First Trust Small Cap Growth AlphaDEX Fund
FYC
0.16%
ProShares Ultra Nasdaq Biotechnology
BIB
0.1034666679171907%
iShares Russell 2000 Growth ETF
IWO
0.04187%
First Trust Multi Cap Growth AlphaDEX Fund
FAD
0.03%
iShares Russell 2000 ETF
IWM
0.02712%
Schwab U.S. Small-Cap ETF
SCHA
0.0153420885%
iShares Russell 2000 Value ETF
IWN
0.01309%
Vanguard Small Cap Index Fund
NAESX
0.01%
Fidelity MSCI Health Care Index ETF
FHLC
0.00776056%
ProShares Hedge Replication ETF
HDG
0.004018517971837164%
iShares Core S&P Total U.S. Stock Market ETF
ITOT
0.00171%
iShares Russell 3000 ETF
IWV
0.00167%
Schwab U.S. Broad Market ETF
SCHB
9.08584e-4%
Goldman Sachs ActiveBeta U.S. Small Cap Equity ETF
GSSC
0%